|
LUZP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.982400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.467750E-01 |
| Normal-vs-Stage2 |
1.063790E-01 |
| Normal-vs-Stage3 |
8.854000E-01 |
| Normal-vs-Stage4 |
4.737200E-01 |
| Stage1-vs-Stage2 |
4.596400E-01 |
| Stage1-vs-Stage3 |
1.182440E-01 |
| Stage1-vs-Stage4 |
7.776400E-02 |
| Stage2-vs-Stage3 |
7.039600E-02 |
| Stage2-vs-Stage4 |
4.184000E-02 |
| Stage3-vs-Stage4 |
5.530200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.010400E-01 |
| Normal-vs-AfricanAmerican |
2.870000E-01 |
| Normal-vs-Asian |
1.625360E-01 |
| Caucasian-vs-AfricanAmerican |
3.464600E-01 |
| Caucasian-vs-Asian |
2.182400E-01 |
| AfricanAmerican-vs-Asian |
9.887000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.536600E-01 |
| Normal-vs-Female |
1.663820E-01 |
| Male-vs-Female |
1.062150E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.176300E-02 |
| Normal-vs-Age(41-60Yrs) |
6.522000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.274400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.347400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.354760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.148020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.403000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.353000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.950800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.670800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.782100E-02 |
| Classical-VS-Follicular |
2.620200E-01 |
| Classical-VS-Other |
9.121600E-02 |
| Classical-VS-Normal |
6.714000E-02 |
| Tall-VS-Follicular |
1.151430E-01 |
| Tall-VS-Other |
6.075400E-01 |
| Tall-VS-Normal |
1.700430E-01 |
| Follicular-VS-Other |
1.816170E-01 |
| Follicular-VS-Normal |
6.054800E-01 |
| Other-VS-Normal |
1.411760E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.097800E-01 |
| Normal-vs-N1 |
5.103800E-01 |
| N0-vs-N1 |
1.948390E-01 |
|
|
